Ephrine Plus Tablet (Caffeine 200 mg, Vitamin C 25 mg) Supplement, ULTRAtab Laboratories, Inc., Highland, NY
Recalling firm: ULTRAtab Laboratories, Inc.
Why it was recalled
cGMP Deviations
Check your package
Compare the exact product and package details with the label you have.
ProductEphrine Plus Tablet (Caffeine 200 mg, Vitamin C 25 mg) Supplement, ULTRAtab Laboratories, Inc., Highland, NY
FDA code information
Product Codes: M943 M943L Bulk Lots: 16K038, 18B075
Match the product, package size, and code together. A missing match does not guarantee safety.
Full FDA record and distribution details
Original product description
Ephrine Plus Tablet (Caffeine 200 mg, Vitamin C 25 mg) Supplement, ULTRAtab Laboratories, Inc., Highland, NY
Recall details
- Recall number
- F-0721-2022
- Event ID
- 89512
- FDA status
- Terminated
- Initiated
- Oct 6, 2021
- Reported
- Feb 16, 2022
- Classified
- Feb 9, 2022
- Terminated
- Sep 1, 2022
- Quantity
- 4,250,842 tablets
- Location
- Highland, NY, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Letter
Where it was distributed
Bulk product was distributed to 2 distributors (NY, FL) who may have repackaged the product and further distributed finished product.
FDA source record · F-0721-2022
Data updated September 16, 2026. View official FDA data ↗
Follow official FDA and manufacturer guidance.